245 related articles for article (PubMed ID: 2016654)
1. Pharmaceuticals as hospital hazards: managing the risks.
McDiarmid MA; Gurley HT; Arrington D
J Occup Med; 1991 Feb; 33(2):155-8. PubMed ID: 2016654
[TBL] [Abstract][Full Text] [Related]
2. Toward more universal precautions.
Clever LH
J Occup Med; 1991 Feb; 33(2):159. PubMed ID: 2016655
[No Abstract] [Full Text] [Related]
3. Comprehensive program for handling hazardous drugs.
Arrington DM; McDiarmid MA
Am J Hosp Pharm; 1993 Jun; 50(6):1170-4. PubMed ID: 8517456
[TBL] [Abstract][Full Text] [Related]
4. [Recent prevention strategies and occupational risk analysis: Control Banding and Sobane].
Ghittori S; Ferrari M; Negri S; Serranti P; Sacco P; Biffi R; Imbriani M
G Ital Med Lav Ergon; 2006; 28(1):30-43. PubMed ID: 16705887
[TBL] [Abstract][Full Text] [Related]
5. OSHA work-practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. Occupational Safety and Health Administration.
Yodaiken RE; Bennett D
Am J Hosp Pharm; 1986 May; 43(5):1193-204. PubMed ID: 3717176
[TBL] [Abstract][Full Text] [Related]
6. Complying with workers' right-to-know legislation.
Knoeck MJ; Wadd WB; Giese RM
Am J Hosp Pharm; 1985 Sep; 42(9):1974-6. PubMed ID: 4050815
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for safe handling of cytotoxic drugs in pharmacy departments and hospital wards.
Hosp Pharm; 1981 Jan; 16(1):17-20. PubMed ID: 10249749
[TBL] [Abstract][Full Text] [Related]
8. Pharmacy implications of the revised OSHA Hazard Communication Standard.
Myers CE
Am J Hosp Pharm; 1989 May; 46(5):990-1. PubMed ID: 2729307
[TBL] [Abstract][Full Text] [Related]
9. Injectable-antineoplastic-drug practices in Michigan hospitals.
Cohen IA; Newland SJ; Kirking DM
Am J Hosp Pharm; 1987 May; 44(5):1096-105. PubMed ID: 3605120
[TBL] [Abstract][Full Text] [Related]
10. Medical surveillance for antineoplastic-drug handlers.
McDiarmid MA
Am J Hosp Pharm; 1990 May; 47(5):1061-6. PubMed ID: 2337095
[TBL] [Abstract][Full Text] [Related]
11. Managing employee apprehension toward handling cytotoxic drugs.
Moore TD; Hale KM; Cortese LM; Fillmore AD; Jozefczyk KG; Scala SM; Wellman GS
Am J Hosp Pharm; 1985 Apr; 42(4):826-31. PubMed ID: 4014233
[TBL] [Abstract][Full Text] [Related]
12. Safe handling of cytotoxic drugs in the physician's office: a procedure manual model.
Carmignani SS; Raymond GG
Oncol Nurs Forum; 1997; 24(1 Suppl):41-8. PubMed ID: 9010864
[TBL] [Abstract][Full Text] [Related]
13. The risks of handling cytotoxic therapy.
Lee L
Nurs Stand; 1993 Aug 25-31; 7(49):25-8. PubMed ID: 8398774
[TBL] [Abstract][Full Text] [Related]
14. Developing guidelines for working with antineoplastic drugs.
Harrison BR
Am J Hosp Pharm; 1981 Nov; 38(11):1686-93. PubMed ID: 7304620
[TBL] [Abstract][Full Text] [Related]
15. Hazards in the hospital.
Seibert PJ
J Am Vet Med Assoc; 1994 Feb; 204(3):352-60. PubMed ID: 8150686
[TBL] [Abstract][Full Text] [Related]
16. [Is the demand for greater safety in handling antineoplastic chemotherapy agents exaggerated?].
Lüderitz P
Z Gesamte Hyg; 1989 Jul; 35(7):407. PubMed ID: 2800646
[No Abstract] [Full Text] [Related]
17. On the problems of agents with mutagenic and carcinogenic effects in health care. Cytostatic drugs.
Medková J
Acta Univ Palacki Olomuc Fac Med; 1990; 126():107-15. PubMed ID: 2151076
[TBL] [Abstract][Full Text] [Related]
18. [Handling of cytostatics and patients care in chemotherapy].
Mast C
Z Gastroenterol; 2002 Apr; 40 Suppl 1():S76-S80. PubMed ID: 11930296
[No Abstract] [Full Text] [Related]
19. ONS advocates for safe handling of hazardous drugs.
Rieger PT
ONS Connect; 2008 Aug; 23(8):29. PubMed ID: 18767574
[No Abstract] [Full Text] [Related]
20. Possible hazards of working with cytotoxic agents: a review of the literature.
Gross J; Johnson BL; Bertino JR
Oncol Nurs Forum; 1981; 8(4):10-2. PubMed ID: 6913042
[No Abstract] [Full Text] [Related]
[Next] [New Search]
